Our team at JPT continues its efforts to support the global scientific community developing vaccines and specific tests for SARS-CoV-2. Today, we are happy to launch Epitope Mapping Peptide Sets (EMPS) for Spike Glycoprotein and Nucleocapsid Proteins.
Each set contains Matrix Pools of overlapping peptides spanning the entire antigen for efficient epitope mapping, as well as all individual peptides for subsequent epitope confirmation and further testing.
To save time and precious sample check out our new SARS-CoV-2 Epitope Mapping Peptide Sets (EMPS).
Learn more about the concept of Matrix Pools.
Visit our web site regularly, or contact us directly, for many more upcoming SARS-CoV-2 related products. Your feedback, questions and suggestions are encouraged!